Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
187 | Advances in Biomolecular Medicine - Proceedings of the 4th BIBMC (Bandung International Biomolecular Medicine Conference) 2016 and the 2nd ACMM (ASEAN Congress on Medical Biotechnology and Molecular | conference and proceedings | 0.101 | 1 | 0 | 29 | 0 | 0 | 27 | 0.00 | 0.00 | 0.00 | |
186 | Frontiers in Anti-infective Drug Discovery | book series | 0.103 Q4 | 3 | 1 | 8 | 141 | 0 | 7 | 0.00 | 141.00 | 0.00 | |
185 | Current Biomarkers | journal | 0.104 Q4 | 3 | 0 | 7 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
184 | Chinese Journal of Cancer Biotherapy | journal | 0.106 Q4 | 5 | 198 | 359 | 6036 | 22 | 354 | 0.06 | 30.48 | 43.78 | |
183 | Journal of Stem Cells | journal | 0.109 Q4 | 21 | 16 | 40 | 1507 | 6 | 39 | 0.24 | 94.19 | 44.90 | |
182 | IEEE International Conference on Nano/Molecular Medicine and Engineering, NANOMED | conference and proceedings | 0.111 | 5 | 0 | 46 | 0 | 12 | 42 | 0.26 | 0.00 | 0.00 | |
181 | European Pharmaceutical Review | trade journal | 0.115 Q4 | 9 | 0 | 143 | 0 | 22 | 140 | 0.04 | 0.00 | 0.00 | |
180 | Clinical and Translational Medicine | journal | 0.125 Q4 | 18 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
179 | Methods in Pharmacology and Toxicology | book series | 0.125 Q4 | 14 | 47 | 169 | 2846 | 109 | 1 | 0.77 | 60.55 | 0.00 | |
178 | Cellular Therapy and Transplantation | journal | 0.126 Q4 | 8 | 31 | 142 | 763 | 26 | 87 | 0.16 | 24.61 | 53.70 | |
177 | Tropical Journal of Natural Product Research | journal | 0.127 Q4 | 11 | 192 | 204 | 7285 | 71 | 197 | 0.33 | 37.94 | 38.80 | |
176 | Current Cancer Therapy Reviews | journal | 0.128 Q4 | 17 | 34 | 51 | 2240 | 19 | 44 | 0.28 | 65.88 | 38.28 | |
175 | MCB Molecular and Cellular Biomechanics | journal | 0.134 Q4 | 31 | 19 | 84 | 474 | 30 | 78 | 0.32 | 24.95 | 43.84 | |
174 | Bulletin of Siberian Medicine | journal | 0.135 Q4 | 9 | 106 | 215 | 2851 | 79 | 215 | 0.37 | 26.90 | 62.93 | |
173 | Yaoxue Xuebao | journal | 0.152 Q4 | 36 | 340 | 770 | 15048 | 402 | 770 | 0.54 | 44.26 | 45.91 | |
172 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 24 | 61 | 1475 | 27 | 56 | 0.40 | 61.46 | 31.15 | |
171 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.185 Q4 | 16 | 44 | 117 | 1553 | 63 | 117 | 0.49 | 35.30 | 46.82 | |
170 | VacciMonitor | journal | 0.190 Q4 | 5 | 20 | 44 | 415 | 13 | 43 | 0.32 | 20.75 | 54.55 | |
169 | Pteridines | journal | 0.198 Q4 | 19 | 19 | 63 | 645 | 37 | 63 | 0.57 | 33.95 | 49.43 | |
168 | Current Pharmaceutical Analysis | journal | 0.210 Q4 | 27 | 137 | 241 | 5109 | 206 | 239 | 0.86 | 37.29 | 44.26 | |
167 | Biointerface Research in Applied Chemistry | journal | 0.216 Q4 | 30 | 320 | 318 | 13811 | 594 | 316 | 2.16 | 43.16 | 41.80 | |
166 | Letters in Drug Design and Discovery | journal | 0.223 Q4 | 37 | 144 | 426 | 5796 | 461 | 413 | 1.11 | 40.25 | 38.05 | |
165 | Current Computer-Aided Drug Design | journal | 0.226 Q4 | 32 | 73 | 111 | 3171 | 129 | 99 | 1.36 | 43.44 | 36.29 | |
164 | Nucleus (India) | journal | 0.232 Q4 | 17 | 35 | 96 | 2136 | 67 | 92 | 0.61 | 61.03 | 41.44 | |
163 | Turkish Journal of Pharmaceutical Sciences | journal | 0.241 Q4 | 22 | 97 | 167 | 3281 | 185 | 167 | 0.96 | 33.82 | 52.66 | |
162 | Current Pharmacogenomics and Personalized Medicine | journal | 0.264 Q4 | 20 | 24 | 37 | 969 | 35 | 33 | 1.24 | 40.38 | 48.57 | |
161 | Drug Discovery Today: Disease Models | journal | 0.268 Q4 | 33 | 23 | 55 | 1686 | 46 | 49 | 0.97 | 73.30 | 72.55 | |
160 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.270 Q4 | 53 | 116 | 157 | 3709 | 223 | 157 | 1.34 | 31.97 | 30.69 | |
159 | Nanomedicine Research Journal | journal | 0.283 Q4 | 20 | 40 | 96 | 1467 | 157 | 96 | 1.39 | 36.68 | 36.60 | |
158 | Proceedings - 2016 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2016 | conference and proceedings | 0.286 | 20 | 0 | 335 | 0 | 362 | 333 | 0.00 | 0.00 | 0.00 | |
157 | Open Medicinal Chemistry Journal | journal | 0.294 Q4 | 23 | 12 | 33 | 758 | 63 | 31 | 1.61 | 63.17 | 48.08 | |
156 | International Journal of Peptide Research and Therapeutics | journal | 0.304 Q4 | 45 | 243 | 268 | 11829 | 406 | 268 | 1.52 | 48.68 | 39.98 | |
155 | Infectious Disorders - Drug Targets | journal | 0.322 Q4 | 61 | 122 | 116 | 4449 | 166 | 112 | 1.47 | 36.47 | 44.14 | |
154 | Journal of Asian Natural Products Research | journal | 0.358 Q4 | 51 | 140 | 422 | 2722 | 612 | 392 | 1.37 | 19.44 | 39.18 | |
153 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.365 Q4 | 45 | 41 | 86 | 1604 | 141 | 81 | 1.64 | 39.12 | 36.49 | |
152 | Topics in Medicinal Chemistry | book series | 0.373 Q4 | 15 | 34 | 113 | 4308 | 74 | 6 | 0.66 | 126.71 | 0.00 | |
151 | Expert Review of Precision Medicine and Drug Development | journal | 0.387 Q4 | 16 | 43 | 115 | 4041 | 151 | 91 | 1.39 | 93.98 | 40.26 | |
150 | Future Cardiology | journal | 0.392 Q4 | 43 | 72 | 185 | 3029 | 254 | 157 | 1.31 | 42.07 | 25.42 | |
149 | Assay and Drug Development Technologies | journal | 0.402 Q4 | 65 | 44 | 118 | 1257 | 167 | 106 | 1.47 | 28.57 | 34.51 | |
148 | International Journal of Molecular and Cellular Medicine | journal | 0.407 Q4 | 22 | 20 | 102 | 1142 | 155 | 100 | 1.26 | 57.10 | 54.17 | |
147 | Planta Medica | journal | 0.422 Q4 | 135 | 131 | 459 | 5761 | 1392 | 442 | 3.15 | 43.98 | 46.61 | |
146 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.427 Q4 | 39 | 20 | 72 | 1147 | 141 | 67 | 2.14 | 57.35 | 39.19 | |
145 | Chemistry and Biodiversity | journal | 0.427 Q4 | 83 | 283 | 680 | 12260 | 1633 | 679 | 2.32 | 43.32 | 42.54 | |
144 | SAR and QSAR in Environmental Research | journal | 0.450 Q4 | 54 | 49 | 166 | 2590 | 410 | 166 | 2.64 | 52.86 | 31.47 | |
143 | Biotechnology and Applied Biochemistry | journal | 0.468 Q4 | 81 | 99 | 307 | 5747 | 657 | 305 | 2.21 | 58.05 | 43.83 | |
142 | Acta Naturae | journal | 0.475 Q3 | 36 | 48 | 157 | 3709 | 305 | 155 | 2.02 | 77.27 | 52.84 | |
141 | Journal of Peptide Science | journal | 0.475 Q3 | 73 | 47 | 242 | 1900 | 469 | 237 | 1.75 | 40.43 | 41.23 | |
140 | Molecular Informatics | journal | 0.481 Q3 | 75 | 67 | 196 | 2810 | 527 | 185 | 2.96 | 41.94 | 27.59 | |
139 | Personalized Medicine | journal | 0.489 Q3 | 36 | 38 | 192 | 2033 | 341 | 157 | 1.56 | 53.50 | 53.55 | |
138 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.508 Q3 | 108 | 231 | 590 | 14800 | 1433 | 572 | 2.31 | 64.07 | 41.05 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®